Rare diseases
Investigational molecules
Locations
Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands
NorthSea Therapeutics B.V. focuses on clinical research in intestinal failure-associated liver disease (IFALD), with attention to the hepatic complications that arise in the setting of impaired intestinal function.
The sponsor’s research activity in this area also includes related clinical interest in bile acid metabolism and intestinal injury.
NorthSea Therapeutics B.V. runs clinical trials in conditions such as Gastrointestinal disorder, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
